R. Hector Mackay-dunn - Net Worth and Insider Trading
R. Hector Mackay-dunn Net Worth
The estimated net worth of R. Hector Mackay-dunn is at least $133,884 dollars as of 2024-09-19. R. Hector Mackay-dunn is the Director of Aurinia Pharmaceuticals Inc and owns about 18,595 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $133,884. Details can be seen in R. Hector Mackay-dunn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that R. Hector Mackay-dunn has not made any transactions after 2024-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of R. Hector Mackay-dunn
R. Hector Mackay-dunn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R. Hector Mackay-dunn owns 1 companies in total, including Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of R. Hector Mackay-dunn’s form 4 insider trades.
Insider Ownership Summary of R. Hector Mackay-dunn
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc | 2024-05-21 | director |
R. Hector Mackay-dunn Latest Holdings Summary
R. Hector Mackay-dunn currently owns a total of 1 stock. R. Hector Mackay-dunn owns 18,595 shares of Aurinia Pharmaceuticals Inc (AUPH) as of May 21, 2024, with a value of $133,884.
Latest Holdings of R. Hector Mackay-dunn
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc | 2024-05-21 | 18,595 | 7.20 | 133,884 |
Holding Weightings of R. Hector Mackay-dunn
R. Hector Mackay-dunn Form 4 Trading Tracker
According to the SEC Form 4 filings, R. Hector Mackay-dunn has made a total of 3 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 5,630 shares on May 21, 2024, which brought R. Hector Mackay-dunn around $32,316.
Insider Trading History of R. Hector Mackay-dunn
- 1
R. Hector Mackay-dunn Trading Performance
GuruFocus tracks the stock performance after each of R. Hector Mackay-dunn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R. Hector Mackay-dunn is 6.15%. GuruFocus also compares R. Hector Mackay-dunn's trading performance to market benchmark return within the same time period. The performance of stocks bought by R. Hector Mackay-dunn within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how R. Hector Mackay-dunn's insider trading performs compared to the benchmark.
Performance of R. Hector Mackay-dunn
R. Hector Mackay-dunn Ownership Network
R. Hector Mackay-dunn Owned Company Details
What does Aurinia Pharmaceuticals Inc do?
Who are the key executives at Aurinia Pharmaceuticals Inc?
R. Hector Mackay-dunn is the director of Aurinia Pharmaceuticals Inc. Other key executives at Aurinia Pharmaceuticals Inc include Chief Commercial Officer Scott Michael Habig , director & Chief Executive Officer Peter Greenleaf , and Chief Financial Officer Joseph M Miller .
Aurinia Pharmaceuticals Inc (AUPH) Insider Trades Summary
Over the past 18 months, R. Hector Mackay-dunn made 2 insider transaction in Aurinia Pharmaceuticals Inc (AUPH) with a net sale of 10,448. Other recent insider transactions involving Aurinia Pharmaceuticals Inc (AUPH) include a net sale of 51,893 shares made by Scott Michael Habig , a net sale of 30,076 shares made by Volker Knappertz , and a net sale of 13,679 shares made by Jayne David R.w. .
In summary, during the past 3 months, insiders sold 18,249 shares of Aurinia Pharmaceuticals Inc (AUPH) in total and bought 0 shares, with a net sale of 18,249 shares. During the past 18 months, 387,417 shares of Aurinia Pharmaceuticals Inc (AUPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 387,417 shares.
Aurinia Pharmaceuticals Inc (AUPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aurinia Pharmaceuticals Inc Insider Transactions
R. Hector Mackay-dunn Mailing Address
Above is the net worth, insider trading, and ownership report for R. Hector Mackay-dunn. You might contact R. Hector Mackay-dunn via mailing address: #1203-4464 Markham Street, Victoria A1 V8z7x8.